RxDoctor Payments Data

Patti Wheeler, MD

Family Medicine · Highlands, NCNPI 1265411169

Payments from drug & device makers

$200in general payments, 2019–2025

Across 15 payments — averaging $13.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$96
  • Irhythm Technologies, Inc.$34
  • Takeda Pharmaceuticals U.S.A., Inc.$28
  • AbbVie$16
  • Dexcom, Inc.$14
  • Novo Nordisk$13

What the payments were for

  • Food & beverage$17286%
  • Education$2814%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$200 in reported general payments places this provider in the 40th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$203,751
Medicare patients
593
Services billed
2,314

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban204$191,518
XareltoRivaroxaban154$147,918
OzempicSemaglutide123$130,717
JardianceEmpagliflozin125$120,963
TymlosAbaloparatide16$42,512
RybelsusSemaglutide36$38,726
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$33,907
MounjaroTirzepatide25$29,747
EntrestoSacubitril/Valsartan40$27,763
Tresiba Flextouch U-100Insulin Degludec48$26,079
MyrbetriqMirabegron48$23,400
Breo ElliptaFluticasone/Vilanterol32$20,166
JanuviaSitagliptin Phosphate17$16,801
TrulicityDulaglutide17$16,598
Effexor XrVenlafaxine Hcl20$15,459

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$13$169,443159 claims
Johnson & JohnsonXarelto$96$147,918154 claims
AbbVieCreon, Synthroid$16$27,522189 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$28$12,43025 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Highlands

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →